CALHM2 and Alzheimer disease: The incidence of CALHM2 V136G mutation (rs232660) was conspicuously greater in AD patients compared to normal controls, disrupted ATP release from astrocytes and brain tissues, causing depressive-like behaviors and cognitive deterioration in adult and aged mice, respectively [9].